1. Home
  2. FCBC vs SVRA Comparison

FCBC vs SVRA Comparison

Compare FCBC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Bankshares Inc. (VA)

FCBC

First Community Bankshares Inc. (VA)

HOLD

Current Price

$47.15

Market Cap

928.3M

Sector

Finance

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

HOLD

Current Price

$5.05

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCBC
SVRA
Founded
1874
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.3M
1.1B
IPO Year
1996
2009

Fundamental Metrics

Financial Performance
Metric
FCBC
SVRA
Price
$47.15
$5.05
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $7.33
AVG Volume (30 Days)
73.2K
★ 1.3M
Earning Date
04-28-2026
05-13-2026
Dividend Yield
★ 5.26%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.82
N/A
Revenue
N/A
N/A
Revenue This Year
$12.28
N/A
Revenue Next Year
$2.55
$430.87
P/E Ratio
$25.69
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$31.21
$3.34
52 Week High
$50.17
$7.01

Technical Indicators

Market Signals
Indicator
FCBC
SVRA
Relative Strength Index (RSI) 42.57 38.18
Support Level $42.49 $4.77
Resistance Level $49.84 $5.48
Average True Range (ATR) 1.01 0.21
MACD -0.14 -0.03
Stochastic Oscillator 44.62 12.33

Price Performance

Historical Comparison
FCBC
SVRA

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: